Bill Type
Long Title
AN ACT NATIONALIZING THE IMPORTATION, MANUFACTURE, SALES AND DISTRIBUTION OF OUT-OF-PATIENT DRUGS AND FOR OTHER PURPOSES
Congress Author
Date filed
August 13, 2007
Scope

Legislative History

House Bill/Resolution NO. HB01985
FULL TITLE : AN ACT NATIONALIZING THE IMPORTATION, MANUFACTURE, SALES AND DISTRIBUTION OF OUT-OF-PATIENT DRUGS AND FOR OTHER PURPOSES
ABSTRACT : The bill seeks to nationalize the manufacture, importation, distribution and sale of out-of-patent drugs. Out-of-patent drugs are, in theory, public properties already. (Cheaper medicines)
PRINCIPAL AUTHOR/S : VELARDE, RENE M.
DATE FILED : 2007-08-13
SIGNIFICANCE: NATIONAL
CO-AUTHORS :
1. Coscolluela 2. Tieng
CO-AUTHORS (Journal Entries) :
1. Ramiro (028 ) 2. Reyes (C.) (005 )
ACTIONS TAKEN BY THE COMMITTEE
COMMITEE HEARINGS/ACTIONS:
      1. Scheduled for first meeting/hearing on 2007-09-11
      2. Under deliberation by the Mother Committee on 2007-09-19
      3. Under deliberation by the Mother Committee on 2007-09-20
      4. Under deliberation by the Mother Committee on 2007-09-24
      5. Under deliberation by the Mother Committee on 2007-09-25
      6. Under study by the Technical Working Group(TWG) on 2007-09-26
      7. Under study by the Technical Working Group(TWG) on 2007-09-27
      8. Under study by the Technical Working Group(TWG) on 2007-09-28
      9. Under deliberation by the Mother Committee on 2007-10-01
      10. Under deliberation by the Mother Committee on 2007-10-02
      11. Under deliberation by the Mother Committee on 2007-10-03
      12. Under deliberation by the Mother Committee on 2007-10-05
MOTHER BILL: HB02844
ACTIONS TAKEN BY THE COMMITTEE ON RULES
REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2007-08-28

Abstract

The bill seeks to nationalize the manufacture, importation, distribution and sale of out-of-patent drugs. Out-of-patent drugs are, in theory, public properties already. (Cheaper medicines)

Disclaimer

Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.